108 related articles for article (PubMed ID: 18769138)
1. T-type calcium channels: from discovery to channelopathies, 25 years of research.
Shuba YM; Perez-Reyes E; Lory P; Noebels J
Channels (Austin); 2008; 2(4):299-302. PubMed ID: 18769138
[No Abstract] [Full Text] [Related]
2. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and new treatment in muscle channelopathies.
Meola G; Hanna MG; Fontaine B
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):360-5. PubMed ID: 19289476
[TBL] [Abstract][Full Text] [Related]
4. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
Hansen PB
Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
[TBL] [Abstract][Full Text] [Related]
5. [Calcium channelopathies: the current challenges].
Lory P; Bidaud I; Mezghrani A; Monteil A
Med Sci (Paris); 2006 Dec; 22(12):1028-31. PubMed ID: 17156720
[No Abstract] [Full Text] [Related]
6. [Physiopathology of calcium channels: identification of calcium channelopathies].
Lory P; Monteil A
C R Seances Soc Biol Fil; 1998; 192(1):137-47. PubMed ID: 9759359
[TBL] [Abstract][Full Text] [Related]
7. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
Akerman S; Williamson DJ; Goadsby PJ
Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
[TBL] [Abstract][Full Text] [Related]
8. Voltage-gated calcium channel blockers deregulate macroautophagy in cardiomyocytes.
Pushparaj C; Das A; Purroy R; Nàger M; Herreros J; Pamplona R; Cantí C
Int J Biochem Cell Biol; 2015 Nov; 68():166-75. PubMed ID: 26429067
[TBL] [Abstract][Full Text] [Related]
9. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
11. Calcium channelopathies.
Lorenzon NM; Beam KG
Kidney Int; 2000 Mar; 57(3):794-802. PubMed ID: 10720931
[TBL] [Abstract][Full Text] [Related]
12. [Human calcium channelopathies. Voltage-gated Ca(2+) channels in etiology, pathogenesis, and pharmacotherapy of neurologic disorders].
Weiergräber M; Hescheler J; Schneider T
Nervenarzt; 2008 Apr; 79(4):426-36. PubMed ID: 18210049
[TBL] [Abstract][Full Text] [Related]
13. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
[TBL] [Abstract][Full Text] [Related]
14. All classes of calcium channel couple with equal efficiency to exocytosis in rat melanotropes, inducing linear stimulus-secretion coupling.
Mansvelder HD; Kits KS
J Physiol; 2000 Jul; 526 Pt 2(Pt 2):327-39. PubMed ID: 10896721
[TBL] [Abstract][Full Text] [Related]
15. T-type calcium channels inhibitors: a patent review.
Giordanetto F; Knerr L; Wållberg A
Expert Opin Ther Pat; 2011 Jan; 21(1):85-101. PubMed ID: 21087200
[TBL] [Abstract][Full Text] [Related]
16. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
17. Structural implications in the function of L-type voltage-dependent calcium channels.
Krizanova O
Gen Physiol Biophys; 1996 Apr; 15(2):79-87. PubMed ID: 8899414
[TBL] [Abstract][Full Text] [Related]
18. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits.
McKeown L; Robinson P; Jones OT
Acta Pharmacol Sin; 2006 Jul; 27(7):799-812. PubMed ID: 16787562
[TBL] [Abstract][Full Text] [Related]
20. Voltage-gated calcium-channels and antiarrhythmic drug action.
Grace AA; Camm AJ
Cardiovasc Res; 2000 Jan; 45(1):43-51. PubMed ID: 10728311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
